UK markets closed

Zentalis Pharmaceuticals, Inc. (ZNTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.68+0.57 (+5.13%)
As of 12:01PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
28,038
43,069
59,714
54,951
Other short-term investments
454,881
394,302
280,173
283,554
Total cash
482,919
437,371
339,887
338,505
Net receivables
-
-
4
417
Other current assets
13,799
14,562
10,640
6,182
Total current assets
496,718
451,933
350,770
345,104
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
44,883
52,138
53,631
3,869
Accumulated depreciation
-3,148
-2,060
-792
-250
Net property, plant and equipment
41,735
50,078
52,839
3,619
Equity and other investments
0
21,213
37,495
0
Goodwill
3,736
3,736
3,736
3,736
Intangible assets
-
-
-
8,800
Other long-term assets
9,499
12,350
9,667
4,296
Total non-current assets
54,970
87,377
103,737
20,451
Total assets
551,688
539,310
454,507
365,555
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
14,926
11,247
11,590
8,661
Taxes payable
-
-
971
410
Accrued liabilities
54,441
45,400
32,354
18,628
Total current liabilities
69,367
56,647
43,944
28,601
Non-current liabilities
Deferred tax liabilities
0
853
1,622
2,480
Other long-term liabilities
1,780
2,620
-
-
Total non-current liabilities
44,930
48,639
46,081
3,577
Total liabilities
114,297
105,286
90,025
32,178
Stockholders' equity
Common stock
70
59
45
41
Retained earnings
-888,556
-596,365
-359,559
-200,834
Accumulated other comprehensive income
2,194
-1,353
-125
36
Total stockholders' equity
437,284
433,803
363,954
308,582
Total liabilities and stockholders' equity
551,688
539,310
454,507
365,555